Evidence map›Paper›PMID 37747504›Full record

ReviewDer Nervenarzt2023

[Epidemiology, diagnostics and treatment of attention deficit-hyperactivity disorder (ADHD) in advanced age].

Peter Praus, Alexander Moldavski, Barbara Alm, Oliver Hennig, Michael Rösler, Wolfgang Retz

Open access · hybridAbstract readEnglish AbstractReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Der Nervenarzt, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Peter PrausZentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, J5, 68159, Mannheim, Deutschland. peter.praus@zi-mannheim.de.
Alexander MoldavskiZentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, J5, 68159, Mannheim, Deutschland.
Barbara AlmZentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, J5, 68159, Mannheim, Deutschland.
Oliver HennigZentralinstitut für Seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, J5, 68159, Mannheim, Deutschland.
Michael RöslerInstitut für Gerichtliche Psychologie und Psychiatrie der Universität des Saarlandes, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Deutschland.
Wolfgang RetzInstitut für Gerichtliche Psychologie und Psychiatrie der Universität des Saarlandes, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Deutschland.
Central Institute of Mental Health · DEJohannes Gutenberg University Mainz · DESaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current studies demonstrate a comparably high prevalence of attention deficit-hyperactivity disorder (ADHD) in advanced age. Older people affected by ADHD suffer from a severe burden of psychiatric and somatic comorbidities as well as substantial impairment of social functioning and subjective well-being. The diagnostic differentiation from neurodegenerative diseases is particularly difficult in this age group. This narrative review summarizes the current knowledge about the epidemiology of ADHD in advanced age and possible relationships between ADHD and the risk for neurodegeneration. Furthermore, recommendations for diagnostics and treatment options of ADHD in advanced age are presented.

Indexed as

Attention Deficit Disorder with HyperactivityAgedComorbidityHumansPrevalenceSocial AdjustmentCareDementiaElderlyHyperkinetic disorderScreening

Identifiers

PMID37747504
PMCPMC10620251
OpenAlexW4387002519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.